SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
AMENDMENT NO. 1
TO
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): October 31, 2000
COVALENT GROUP, INC.
--------------------
(Exact name of issuer as specified in charter)
Nevada 0-21145 56-1668867
(State or Other Jurisdiction (Commission (I.R.S. Employer
of Incorporation or file Identification
Organization) number) Number)
One Glenhardie Corporate Center
1275 Drummers Lane
Suite 100
Wayne, Pennsylvania 19087
(Address of principal executive offices)
(610) 975-9533
(Registrant's telephone number, including area code)
ITEM 4. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNT
On October 31, 2000, Covalent Group, Inc. (the "Company") replaced Arthur
Andersen LLP ("Andersen"), its independent public accountants, with
Deloitte & Touche, LLP ("Deloitte") in accordance with a resolution of the
Company's board of directors. Andersen previously audited the Company's
financial statements for the years ended December 31, 1997 through December
31, 1999.
The reports of Andersen on the Company's financial statements for the years
ended December 31, 1997 through December 31, 1999, did not contain an
adverse opinion or a disclaimer of opinion and were not qualified or
modified as to uncertainty, audit scope or accounting principles. During
the same period, and for the subsequent interim period through October 31,
2000, there were no disagreements with Andersen on any matter of accounting
principles or practices, financial statement disclosure or auditing scope
or procedure.
Pursuant to Item 304(a)(3) of Regulation S-B, the Company has requested
Andersen to furnish it a letter addressed to the Securities and Exchange
Commission stating whether it agrees with the above statements. A copy of
that letter is filed as an Exhibit to this Form 8-K.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND
EXHIBITS
Exhibit
16 Letter from Andersen to the Company dated November 16, 2000.
SIGNATURE
Pursuant to the requirements of the Securities and Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by
the undersigned duly authorized.
Date: November 16, 2000 Covalent Group, Inc.
/s/ Kenneth M. Borow, M.D.
---------------------------------------
Kenneth M. Borow, M.D.
Chief Executive Officer and President
EXHIBIT INDEX
Exhibit
No. Description
- ------- -----------
16 Letter from Andersen to the Company dated November 16, 2000.